Last edition
News about "personalised cancer therapies "
Sanguine Expands Oncology Biospecimen Access via Clinic Partnerships
Through these partnerships, Sanguine now offers researchers access to a growing inventory of oncology biospecimens, including blood, plasma, serum and peripheral blood mononuclear cells (PBMCs), collected using minimally invasive methods to reduce donor burden and accelerate study timelines.
Personalised Cancer Therapies | 17/09/2025 | By Dineshwori
SeqOne Strengthens UK Presence with Acquisition of Congenica
The acquisition of UK genomics leader Congenica strengthens SeqOne’s market position and global footprint, servicing over 160 labs in more than 30 countries.
Personalised Cancer Therapies | 03/09/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy